These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17785429)

  • 1. The growth hormone/insulin-like growth factor-I axis in exercise and sport.
    Gibney J; Healy ML; Sönksen PH
    Endocr Rev; 2007 Oct; 28(6):603-24. PubMed ID: 17785429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The physiology of growth hormone and sport.
    Widdowson WM; Healy ML; Sönksen PH; Gibney J
    Growth Horm IGF Res; 2009 Aug; 19(4):308-19. PubMed ID: 19505835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport.
    Wallace JD; Cuneo RC; Baxter R; Orskov H; Keay N; Pentecost C; Dall R; Rosén T; Jørgensen JO; Cittadini A; Longobardi S; Sacca L; Christiansen JS; Bengtsson BA; Sönksen PH
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3591-601. PubMed ID: 10523001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term administration of supraphysiological recombinant human growth hormone (GH) does not increase maximum endurance exercise capacity in healthy, active young men and women with normal GH-insulin-like growth factor I axes.
    Berggren A; Ehrnborg C; Rosén T; Ellegård L; Bengtsson BA; Caidahl K
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3268-73. PubMed ID: 15784718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the somatopause an indication for growth hormone replacement?
    Savine R; Sönksen PH
    J Endocrinol Invest; 1999; 22(5 Suppl):142-9. PubMed ID: 10442584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward the development of a test for growth hormone (GH) abuse: a study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition setting.
    Healy ML; Dall R; Gibney J; Bassett E; Ehrnborg C; Pentecost C; Rosen T; Cittadini A; Baxter RC; Sönksen PH
    J Clin Endocrinol Metab; 2005 Feb; 90(2):641-9. PubMed ID: 15546908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test.
    Ehrnborg C; Lange KH; Dall R; Christiansen JS; Lundberg PA; Baxter RC; Boroujerdi MA; Bengtsson BA; Healey ML; Pentecost C; Longobardi S; Napoli R; Rosén T;
    J Clin Endocrinol Metab; 2003 Jan; 88(1):394-401. PubMed ID: 12519882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults.
    Woodhouse LJ; Mukherjee A; Shalet SM; Ezzat S
    Endocr Rev; 2006 May; 27(3):287-317. PubMed ID: 16543384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
    Carroll PV; Drake WM; Maher KT; Metcalfe K; Shaw NJ; Dunger DB; Cheetham TD; Camacho-Hübner C; Savage MO; Monson JP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-I abuse in sport: current knowledge and future prospects for detection.
    Guha N; Sönksen PH; Holt RI
    Growth Horm IGF Res; 2009 Aug; 19(4):408-11. PubMed ID: 19467615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and physical performance.
    Birzniece V; Nelson AE; Ho KK
    Trends Endocrinol Metab; 2011 May; 22(5):171-8. PubMed ID: 21420315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone administration: is it safe and effective for athletic performance.
    Birzniece V; Nelson AE; Ho KK
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):11-23, vii. PubMed ID: 20122446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased pulsatility, process irregularity, and nocturnal trough concentrations of growth hormone in amenorrheic compared to eumenorrheic athletes.
    Waters DL; Qualls CR; Dorin R; Veldhuis JD; Baumgartner RN
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1013-9. PubMed ID: 11238479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone and exercise: physiology, use and abuse.
    Jenkins PJ
    Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S71-7. PubMed ID: 11527092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease: a dose-finding study.
    Toogood AA; Shalet SM
    J Clin Endocrinol Metab; 1999 Jan; 84(1):131-6. PubMed ID: 9920073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men.
    Taaffe DR; Pruitt L; Reim J; Hintz RL; Butterfield G; Hoffman AR; Marcus R
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1361-6. PubMed ID: 7525633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults.
    Yuen KC; Dunger DB
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S55-61. PubMed ID: 16624605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.